Monongahela Valley Hospital, Inc. Hospital Units - Psychiatric Unit Medicare: Medicare Enrolled Practice Location: 1163 Country Club Road, Monongahela, PA 15063 Phone: 724-258-1160 Fax: 724-258-1394 |
Wholelife Integrative Therapy, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 416 W Main St, Monongahela, PA 15063 Phone: 724-986-0479 |
Sacred. Centered. You, Llc Counselor Medicare: Not Enrolled in Medicare Practice Location: 25 Carol Ave, Monongahela, PA 15063 Phone: 421-258-0766 |
News Archive
Buckeye Health Plan recognized Asif Younus, M. D., of Stark Pediatrics, Inc., in Canton with a Physician Summit Award, the company's highest designation for a health care provider. Summit Awards are given each year to primary care physicians and obstetricians for providing clinical excellence.
Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD).
Asia accounts for more than half of the over five million global deaths attributed to ambient cold and hot temperatures, according to an international study. But many governments are failing to prioritize health in their climate change strategies, experts warn.
Politco Pro describes the growing focus on this part of the insurance marketplace as a "sleeper battle to watch." Meanwhile, Reuters reports that a growing number of people are signing up for supplemental insurance coverage.
XCELERON, a leader in the field of ultra-sensitive bioanalytical studies supporting clinical research, today announced that it has signed a second Master Service Agreement with GlaxoSmithKline. Under the terms of this agreement, Xceleron will provide analytical support to GlaxoSmithKline and its affiliated research organizations. As part of the deal, Xceleron will increase capacity through the acquisition of an Accelerator Mass Spectrometry (AMS) instrument.
› Verified 2 days ago